ZA745252B - New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them - Google Patents

New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them

Info

Publication number
ZA745252B
ZA745252B ZA00745252A ZA745252A ZA745252B ZA 745252 B ZA745252 B ZA 745252B ZA 00745252 A ZA00745252 A ZA 00745252A ZA 745252 A ZA745252 A ZA 745252A ZA 745252 B ZA745252 B ZA 745252B
Authority
ZA
South Africa
Prior art keywords
halogen
derivatives
pyrozoles
producing
medicaments containing
Prior art date
Application number
ZA00745252A
Other languages
English (en)
Inventor
R Riedel
G Rainer
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of ZA745252B publication Critical patent/ZA745252B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00745252A 1973-08-16 1974-08-15 New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them ZA745252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU68238A LU68238A1 (xx) 1973-08-16 1973-08-16

Publications (1)

Publication Number Publication Date
ZA745252B true ZA745252B (en) 1976-03-31

Family

ID=19727442

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00745252A ZA745252B (en) 1973-08-16 1974-08-15 New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them

Country Status (18)

Country Link
JP (1) JPS5230515B2 (xx)
AT (1) AT339892B (xx)
BE (1) BE818912A (xx)
CA (1) CA1048499A (xx)
CH (1) CH601250A5 (xx)
DE (2) DE2438779C3 (xx)
DK (1) DK136953B (xx)
ES (1) ES429247A1 (xx)
FI (1) FI57584C (xx)
FR (1) FR2240732B1 (xx)
GB (1) GB1475806A (xx)
IE (1) IE39999B1 (xx)
LU (1) LU68238A1 (xx)
NL (1) NL169070C (xx)
NO (1) NO140733C (xx)
SE (1) SE409454B (xx)
YU (1) YU222474A (xx)
ZA (1) ZA745252B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297383A (en) * 1976-02-13 1977-08-16 Ngk Spark Plug Co Ceramic honeycomb structures for exhaust gas purification
HUP0304101A3 (en) * 2003-12-22 2008-10-28 Sanofi Aventis Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
IE39999L (en) 1975-02-16
IE39999B1 (en) 1979-02-14
FR2240732A1 (xx) 1975-03-14
YU222474A (en) 1983-04-27
DK136953C (xx) 1978-05-29
FI57584C (fi) 1980-09-10
NO742941L (xx) 1975-03-17
DE2462459A1 (de) 1977-04-07
CH601250A5 (xx) 1978-06-30
NL169070B (nl) 1982-01-04
DK438174A (xx) 1975-04-28
FR2240732B1 (xx) 1978-07-21
DE2438779C3 (de) 1979-09-20
GB1475806A (en) 1977-06-10
JPS5049278A (xx) 1975-05-01
FI242274A (xx) 1975-02-17
LU68238A1 (xx) 1975-05-21
NL7410921A (nl) 1975-02-18
FI57584B (fi) 1980-05-30
SE409454B (sv) 1979-08-20
NO140733C (no) 1979-10-31
SE7410419L (xx) 1975-02-17
ATA671174A (de) 1977-03-15
NO140733B (no) 1979-07-23
AT339892B (de) 1977-11-10
DE2438779A1 (de) 1975-02-27
ES429247A1 (es) 1976-08-16
CA1048499A (en) 1979-02-13
DE2462459C3 (de) 1979-10-04
BE818912A (fr) 1975-02-17
DK136953B (da) 1977-12-19
DE2462459B2 (de) 1979-02-08
DE2438779B2 (de) 1979-01-25
NL169070C (nl) 1982-06-01
JPS5230515B2 (xx) 1977-08-09

Similar Documents

Publication Publication Date Title
IL40971A0 (en) Substituted pyrimidone-(4) derivatives,a method for producing them and medicaments containing them
HU172697B (hu) Sposob poluchenija proizvodnykh tieno-skobka-2,3-c-skobka zakryta-piridina
HU173540B (hu) Sposob poluchenija novykh proizvodnykh 5-oksa-prostaglandina
HU171401B (hu) Sposob poluchenija proizvodnykh 2-alkoksial'kil-1,4-digidropiridina
YU204274A (en) Process for preparing new dibenzoxepin derivatives
HK7977A (en) Pyrazole derivatives, process for their preparation and their use as medicaments
IL45823A0 (en) Basically substituted 1,4-dihydro-2h-isoquinoline derivatives and process for preparing them
HU172465B (hu) Sposob poluchenija novykh proizvodnykh tiaprostaglandina
HU173985B (hu) Sposob poluchenija proizvodnykh d-8al'fa,8beta-dvezamehhjonnogo-6-metil-ehrgolina i -ehrgolena
ZA746435B (en) Triglycidyl compounds, a process for their manufacture and their use
BG24226A3 (en) Method of preparing derivatives of 2-aminomethyl-4,6-dihalidephenol
YU102382A (en) Process for preparing new benzodiazepine derivatives
HU175423B (hu) Sposob poluchenija novykh proizvodnykh pirazola
ZA745252B (en) New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them
HU173395B (hu) Sposob poluchenija proizvodnykh estren-3,17-diona
HU172101B (hu) Sposob poluchenija novykh proizvodnykh 2,3-dioksopiperazina
HU171165B (hu) Sposob poluchenija proizvodnykh oktagidro-indolo-skobka-2,3-a-skobka zakryta-kinolizina
HU172063B (hu) Sposob poluchenija priozvodnykh n-skobka-5-tetrazolil-skobka zakryta-1-okso-6-alkoksi-1h-pirimido-skobka-1,2-a-skobka zakryta-kinolin-2-karboksamidov
HU172055B (hu) Sposob poluchenija proizvodnykh tieno-skobka-3,2-c-skobka zakryta-piridina
HU174067B (hu) Sposob poluchenija zamehhennykh proizvodnykh 2h-piran-2,6-diona
HU171824B (hu) Sposob poluchenija novykh proizvodnykh 2,3-metilen-prostaglandinov
HU172343B (hu) Sposob poluchenija proizvodnykh 1,2,4-triazola
HU173039B (hu) Sposob poluchenija proizvodnykh 9-alkoksi- ili- -alliloksi-5-alkil- ili -alkenil-6,7-benzomorfanov
ZA746632B (en) Basically substiduted 1,4-dihydro-2h-isoquinoline derivatives and process for preparing them
CA1020947A (en) Substituted 2-hydrazonomethyl-3-hydroxy-4-aza-2,4-pentadienenitriles, a method for producing them and medicaments containing them